Nurse Anesthetist - CR in Casa Grande, AZ Accepting Medicare

3 Nurse Anesthetist - CR nurses found. Showing 1 - 3

Garland Munns, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 1800 E Florence Blvd, Casa Grande, AZ 85122 Phone: 520-381-6300

Mr. Michael Pryor, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 1760 E Florence Blvd, Casa Grande, AZ 85222 Phone: 602-273-6770    Fax: 602-889-0489

Mrs. Karen L Fairlamb, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1800 E Florence Blvd, Casa Grande, AZ 85222 Phone: 520-426-6503

News Archive

Targeting SARS-CoV-2 with off-the-shelf CAR-NK cells

The current COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread and cause disease and death in many countries even today. At present, there is no effective treatment. A recent study published on the preprint server bioRxiv in August 2020 reports the potential of a new class of drugs called CAR NK cells, which could be used off-the-shelf to treat this disease.

Alliance of Medicare providers urge link between payment changes, quality

The Premier healthcare alliance is urging that, if scheduled 2 percent cuts take effect, they not apply to hospitals that have already reduced costs.

Study focuses on improving pharmacokinetic properties of therapeutic aptamers

Designing new therapeutic DNA aptamers with diverse side chains can improve their ability to interact with targets, and a new study describes characteristics of these side chains that may determine how long the aptamers remain in the bloodstream.

Upcoming phase II study to discover personalized therapy for patients at high risk for breast cancer relapse

Indiana University School of Medicine researchers Milan Radovich, PhD, and Bryan Schneider, MD, have discovered that the presence of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) in the plasma of women's blood who have undergone chemotherapy prior to surgery for the treatment of stage 1, 2 or 3 triple negative breast cancer are critical indicators for the prediction of disease recurrence and disease-free survival.

Read more Medical News

› Verified 7 days ago